Methods and compositions for treating complement-associated disorders

Details for Australian Patent Application No. 2009313203 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Rother, Russell P.; Bedrosian, Camille; Squinto, Stephen P.; Bell, Leonard

Agent Shelston IP

Pub. Number AU-A-2009313203

PCT Pub. Number WO2010/054403

Priority 61/199,764 19.11.08 US; 61/199,569 18.11.08 US; 61/181,788 28.05.09 US; 61/228,047 23.07.09 US; 61/199,562 18.11.08 US; 61/198,803 10.11.08 US; 61/200,635 01.12.08 US; 61/200,634 01.12.08 US; 61/200,640 01.12.08 US; 61/199,563 18.11.08 US

Filing date 10 November 2009

Wipo publication date 14 May 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/054403 Priority application(s): WO2010/054403

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313204-Multi-fire stapling systems and methods for delivering arrays of staples

2009313201-Novel lipids and compositions for the delivery of therapeutics